Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation.
Bone marrow transplantation
View this publicationMember, Steering-Committee Member
Medical Faculty, University of Bonn University Hospital of Bonn Venusberg - Campus 1 53127 Bonn
Dr. Heine and her group are interested in the mechanisms governing antigen cross-presentation and cytotoxic T cell induction in the context of anti-tumor immune responses. Effective cancer vaccines should not only induce strong and durable T cell responses, but also optimally modulate the balance between suppressive and stimulatory factors in the tumor microenvironment. The aim of her research is the identification of novel immunotherapeutic strategies that accomplish both, with a special focus on different pathways of dendritic cell licensing and chemokine receptor modulation.
Bone marrow transplantation
View this publicationCancer treatment and research communications
View this publicationInternational journal of molecular sciences
View this publication